$GILD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GILEAD SCIENCES INC. Get notifications about new insider transactions in GILEAD SCIENCES INC for free.
Page: < prev 1 ... 40 41 42 43 44 45 46 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 23 2004 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | M | 28.50 | 6,000 | 171,000 | 0 | |
| Nov 23 2004 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | M | 29.21 | 36,000 | 1,051,380 | 0 | |
| Nov 23 2004 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | M | 17.16 | 10,000 | 171,625 | 135,600 | |
| Nov 23 2004 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | M | 16.25 | 10,800 | 175,446 | 21,600 | |
| Nov 23 2004 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Sell | S | 34.52 | 104,800 | 3,617,256 | 0 | 104.8 K to 0 (-100.00 %) |
| Nov 23 2004 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Buy | M | 31.40 | 42,000 | 1,318,800 | 104,800 | 62.8 K to 104.8 K (+66.88 %) |
| Nov 23 2004 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Buy | M | 28.50 | 6,000 | 171,000 | 62,800 | 56.8 K to 62.8 K (+10.56 %) |
| Nov 23 2004 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Buy | M | 29.21 | 36,000 | 1,051,380 | 56,800 | 20.8 K to 56.8 K (+173.08 %) |
| Nov 23 2004 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Buy | M | 17.16 | 10,000 | 171,625 | 20,800 | 10.8 K to 20.8 K (+92.59 %) |
| Nov 23 2004 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Buy | M | 16.25 | 10,800 | 175,446 | 10,800 | 0 to 10.8 K |
| Nov 16 2004 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Option Exercise | M | 4.00 | 40,000 | 160,000 | 40,000 | |
| Nov 16 2004 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 36.90 | 5,000 | 184,500 | 10,000 | 15 K to 10 K (-33.33 %) |
| Nov 16 2004 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 36.81 | 5,000 | 184,050 | 15,000 | 20 K to 15 K (-25.00 %) |
| Nov 16 2004 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 36.71 | 5,000 | 183,550 | 20,000 | 25 K to 20 K (-20.00 %) |
| Nov 16 2004 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 36.70 | 5,000 | 183,500 | 25,000 | 30 K to 25 K (-16.67 %) |
| Nov 16 2004 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 36.95 | 5,000 | 184,750 | 30,000 | 35 K to 30 K (-14.29 %) |
| Nov 16 2004 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 37.06 | 4,000 | 148,240 | 35,000 | 39 K to 35 K (-10.26 %) |
| Nov 16 2004 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 37.09 | 1,000 | 37,090 | 39,000 | 40 K to 39 K (-2.50 %) |
| Nov 16 2004 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Buy | M | 4.00 | 40,000 | 160,000 | 40,000 | 0 to 40 K |
| Nov 12 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Option Exercise | M | 4.78 | 8,000 | 38,250 | 116,000 | |
| Nov 12 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 35.99 | 8,000 | 287,920 | 8,000 | 16 K to 8 K (-50.00 %) |
| Nov 12 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Grant | A | 4.78 | 8,000 | 38,250 | 16,000 | 8 K to 16 K (+100.00 %) |
| Nov 12 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Option Exercise | M | 4.78 | 8,000 | 38,250 | 116,000 | |
| Nov 12 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 35.99 | 8,000 | 287,920 | 8,000 | 16 K to 8 K (-50.00 %) |
| Nov 12 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Grant | A | 4.78 | 8,000 | 38,250 | 16,000 | 8 K to 16 K (+100.00 %) |
| Nov 12 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Option Exercise | M | 7.08 | 10,000 | 70,782 | 28,000 | |
| Nov 12 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 35.99 | 23,260 | 837,127 | 1,432 | 24.7 K to 1.4 K (-94.20 %) |
| Nov 12 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 36.02 | 2,000 | 72,040 | 24,692 | 26.7 K to 24.7 K (-7.49 %) |
| Nov 12 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 36.01 | 100 | 3,601 | 26,692 | 26.8 K to 26.7 K (-0.37 %) |
| Nov 12 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 35.99 | 7,900 | 284,321 | 26,792 | 34.7 K to 26.8 K (-22.77 %) |
| Nov 12 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Buy | M | 7.08 | 10,000 | 70,782 | 34,692 | 24.7 K to 34.7 K (+40.50 %) |
| Nov 09 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Option Exercise | M | 7.08 | 60,800 | 430,355 | 0 | |
| Nov 09 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Option Exercise | M | 2.86 | 632 | 1,807 | 19,200 | |
| Nov 09 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 37.50 | 61,432 | 2,303,927 | 13,434 | 74.9 K to 13.4 K (-82.06 %) |
| Nov 09 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Buy | M | 7.08 | 60,800 | 430,355 | 74,866 | 14.1 K to 74.9 K (+432.25 %) |
| Nov 09 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Buy | M | 2.86 | 632 | 1,807 | 14,066 | 13.4 K to 14.1 K (+4.70 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 4.09 | 120,000 | 491,256 | 306,720 | |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.09 | 1,600 | 59,344 | 667,014 | 668.6 K to 667 K (-0.24 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.00 | 1,000 | 37,000 | 668,614 | 669.6 K to 668.6 K (-0.15 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.03 | 962 | 35,623 | 669,614 | 670.6 K to 669.6 K (-0.14 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.05 | 6,143 | 227,598 | 670,576 | 676.7 K to 670.6 K (-0.91 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.06 | 2,600 | 96,356 | 676,719 | 679.3 K to 676.7 K (-0.38 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.07 | 2,000 | 74,140 | 679,319 | 681.3 K to 679.3 K (-0.29 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.08 | 400 | 14,832 | 681,319 | 681.7 K to 681.3 K (-0.06 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.10 | 1,600 | 59,360 | 681,719 | 683.3 K to 681.7 K (-0.23 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.11 | 7,657 | 284,151 | 683,319 | 691 K to 683.3 K (-1.11 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.50 | 29,100 | 1,091,250 | 690,976 | 720.1 K to 691 K (-4.04 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.51 | 100 | 3,751 | 720,076 | 720.2 K to 720.1 K (-0.01 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.52 | 1,638 | 61,458 | 720,176 | 721.8 K to 720.2 K (-0.23 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.53 | 200 | 7,506 | 721,814 | 722 K to 721.8 K (-0.03 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.58 | 10,000 | 375,800 | 722,014 | 732 K to 722 K (-1.37 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.60 | 5,000 | 188,000 | 732,014 | 737 K to 732 K (-0.68 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.63 | 10,000 | 376,300 | 737,014 | 747 K to 737 K (-1.34 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.76 | 5,000 | 188,800 | 747,014 | 752 K to 747 K (-0.66 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.80 | 5,000 | 189,000 | 752,014 | 757 K to 752 K (-0.66 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.86 | 5,000 | 189,300 | 757,014 | 762 K to 757 K (-0.66 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.89 | 5,000 | 189,450 | 762,014 | 767 K to 762 K (-0.65 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.90 | 5,000 | 189,500 | 767,014 | 772 K to 767 K (-0.65 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.92 | 10,000 | 379,200 | 772,014 | 782 K to 772 K (-1.28 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.94 | 5,000 | 189,700 | 782,014 | 787 K to 782 K (-0.64 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 4.09 | 120,000 | 491,256 | 787,014 | 667 K to 787 K (+17.99 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 4.09 | 120,000 | 491,256 | 306,720 | |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.09 | 1,600 | 59,344 | 667,014 | 668.6 K to 667 K (-0.24 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.00 | 1,000 | 37,000 | 668,614 | 669.6 K to 668.6 K (-0.15 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.03 | 962 | 35,623 | 669,614 | 670.6 K to 669.6 K (-0.14 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.05 | 6,143 | 227,598 | 670,576 | 676.7 K to 670.6 K (-0.91 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.06 | 2,600 | 96,356 | 676,719 | 679.3 K to 676.7 K (-0.38 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.07 | 2,000 | 74,140 | 679,319 | 681.3 K to 679.3 K (-0.29 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.08 | 400 | 14,832 | 681,319 | 681.7 K to 681.3 K (-0.06 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.10 | 1,600 | 59,360 | 681,719 | 683.3 K to 681.7 K (-0.23 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.11 | 7,657 | 284,151 | 683,319 | 691 K to 683.3 K (-1.11 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.50 | 29,100 | 1,091,250 | 690,976 | 720.1 K to 691 K (-4.04 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.51 | 100 | 3,751 | 720,076 | 720.2 K to 720.1 K (-0.01 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.52 | 1,638 | 61,458 | 720,176 | 721.8 K to 720.2 K (-0.23 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.53 | 200 | 7,506 | 721,814 | 722 K to 721.8 K (-0.03 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.58 | 10,000 | 375,800 | 722,014 | 732 K to 722 K (-1.37 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.60 | 5,000 | 188,000 | 732,014 | 737 K to 732 K (-0.68 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.63 | 10,000 | 376,300 | 737,014 | 747 K to 737 K (-1.34 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.76 | 5,000 | 188,800 | 747,014 | 752 K to 747 K (-0.66 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.80 | 5,000 | 189,000 | 752,014 | 757 K to 752 K (-0.66 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.86 | 5,000 | 189,300 | 757,014 | 762 K to 757 K (-0.66 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.89 | 5,000 | 189,450 | 762,014 | 767 K to 762 K (-0.65 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.90 | 5,000 | 189,500 | 767,014 | 772 K to 767 K (-0.65 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.92 | 10,000 | 379,200 | 772,014 | 782 K to 772 K (-1.28 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.94 | 5,000 | 189,700 | 782,014 | 787 K to 782 K (-0.64 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 4.09 | 120,000 | 491,256 | 787,014 | 667 K to 787 K (+17.99 %) |
| Nov 05 2004 | GILD | GILEAD SCIENCES IN ... | DAVIGNON ETIENNE | Director | Grant | A | 0.00 | 5,000 | 0 | 317,000 | 312 K to 317 K (+1.60 %) |
| Nov 04 2004 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | A | 35.35 | 235,860 | 8,337,651 | 235,860 | |
| Nov 04 2004 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | A | 35.35 | 14,140 | 499,849 | 14,140 | |
| Nov 03 2004 | GILD | GILEAD SCIENCES IN ... | MOORE GORDON EARLE | Director | Sell | S | 34.92 | 770 | 26,888 | 0 | 770 to 0 (-100.00 %) |
| Nov 02 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Gift | G | 0.00 | 200 | 0 | 4,434 | 4.6 K to 4.4 K (-4.32 %) |
| Nov 02 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 35.33 | 9,400 | 332,102 | 4,634 | 14 K to 4.6 K (-66.98 %) |
| Nov 03 2004 | GILD | GILEAD SCIENCES IN ... | MOORE GORDON EARLE | Director | Sell | S | 34.92 | 770 | 26,888 | 0 | 770 to 0 (-100.00 %) |
| Oct 29 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Option Exercise | M | 7.30 | 180,000 | 1,313,442 | 166,296 | |
| Oct 29 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Gift | G | 0.00 | 500 | 0 | 92,772 | 93.3 K to 92.8 K (-0.54 %) |
| Oct 29 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Gift | G | 0.00 | 800 | 0 | 93,272 | 94.1 K to 93.3 K (-0.85 %) |
| Oct 29 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Sell | S | 35.00 | 32,500 | 1,137,500 | 415,550 | 448.1 K to 415.6 K (-7.25 %) |
| Oct 29 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Sell | S | 35.05 | 2,500 | 87,625 | 448,050 | 450.6 K to 448.1 K (-0.55 %) |
| Oct 29 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Sell | S | 35.20 | 75,000 | 2,640,000 | 450,550 | 525.6 K to 450.6 K (-14.27 %) |
| Oct 29 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Sell | S | 35.28 | 40,000 | 1,411,252 | 525,550 | 565.6 K to 525.6 K (-7.07 %) |
| Oct 29 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Sell | S | 35.29 | 12,500 | 441,163 | 565,550 | 578.1 K to 565.6 K (-2.16 %) |
| Oct 29 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Sell | S | 35.30 | 10,000 | 353,000 | 578,050 | 588.1 K to 578.1 K (-1.70 %) |
| Oct 29 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Sell | S | 35.34 | 7,500 | 265,050 | 588,050 | 595.6 K to 588.1 K (-1.26 %) |
| Oct 29 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Buy | M | 7.30 | 180,000 | 1,313,442 | 595,550 | 415.6 K to 595.6 K (+43.32 %) |
| Oct 13 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Option Exercise | M | 4.78 | 8,000 | 38,250 | 124,000 | |
| Oct 13 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 38.30 | 8,000 | 306,400 | 8,000 | 16 K to 8 K (-50.00 %) |
| Oct 13 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Grant | A | 4.78 | 8,000 | 38,250 | 16,000 | 8 K to 16 K (+100.00 %) |
| Oct 28 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 7.41 | 22,000 | 162,939 | 680 | |
| Oct 28 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 34.51 | 500 | 17,255 | 89,596 | 90.1 K to 89.6 K (-0.55 %) |
| Oct 28 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 34.50 | 21,500 | 741,750 | 90,096 | 111.6 K to 90.1 K (-19.27 %) |
| Oct 28 2004 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 7.41 | 22,000 | 162,939 | 111,596 | 89.6 K to 111.6 K (+24.55 %) |
| Sep 09 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Option Exercise | M | 4.78 | 8,000 | 38,250 | 132,000 | |
| Sep 09 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 34.65 | 8,000 | 277,200 | 8,000 | 16 K to 8 K (-50.00 %) |
| Sep 09 2004 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Grant | A | 4.78 | 8,000 | 38,250 | 16,000 | 8 K to 16 K (+100.00 %) |
| Sep 01 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Option Exercise | M | 14.59 | 8,148 | 118,910 | 0 | |
| Sep 01 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Option Exercise | M | 6.59 | 80 | 528 | 0 | |
| Sep 01 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Option Exercise | M | 6.59 | 422 | 2,783 | 8,498 | |
| Sep 01 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 68.63 | 850 | 58,336 | 13,846 | 14.7 K to 13.8 K (-5.78 %) |
| Sep 01 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 68.62 | 200 | 13,724 | 14,696 | 14.9 K to 14.7 K (-1.34 %) |
| Sep 01 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 68.61 | 300 | 20,583 | 14,896 | 15.2 K to 14.9 K (-1.97 %) |
| Sep 01 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 68.64 | 850 | 58,344 | 15,196 | 16 K to 15.2 K (-5.30 %) |
| Sep 01 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 68.63 | 7,100 | 487,273 | 16,046 | 23.1 K to 16 K (-30.67 %) |
| Sep 01 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Sell | S | 68.65 | 700 | 48,055 | 23,146 | 23.8 K to 23.1 K (-2.94 %) |
| Sep 01 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Buy | M | 14.59 | 8,148 | 118,910 | 23,846 | 15.7 K to 23.8 K (+51.90 %) |
| Sep 01 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Buy | M | 6.59 | 422 | 2,783 | 15,698 | 15.3 K to 15.7 K (+2.76 %) |
| Sep 01 2004 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP | Buy | M | 6.59 | 80 | 527 | 15,276 | 15.2 K to 15.3 K (+0.53 %) |
| Aug 19 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Option Exercise | M | 6.59 | 3,968 | 26,164 | 0 | |
| Aug 19 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Option Exercise | M | 6.59 | 30,032 | 198,025 | 3,968 | |
| Aug 19 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 64.68 | 12,136 | 784,956 | 36,894 | 49 K to 36.9 K (-24.75 %) |
| Aug 19 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 64.70 | 481 | 31,121 | 49,030 | 49.5 K to 49 K (-0.97 %) |
| Aug 19 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 64.66 | 100 | 6,466 | 49,511 | 49.6 K to 49.5 K (-0.20 %) |
| Aug 19 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 64.65 | 21,403 | 1,383,704 | 49,611 | 71 K to 49.6 K (-30.14 %) |
| Aug 19 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 64.67 | 2,000 | 129,340 | 6,000 | 8 K to 6 K (-25.00 %) |
| Aug 19 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 64.66 | 100 | 6,466 | 8,000 | 8.1 K to 8 K (-1.23 %) |
| Aug 19 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 64.65 | 1,868 | 120,766 | 8,100 | 10 K to 8.1 K (-18.74 %) |
| Aug 19 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Buy | M | 6.59 | 3,968 | 26,164 | 9,968 | 6 K to 10 K (+66.13 %) |
| Aug 19 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 64.73 | 932 | 60,328 | 6,000 | 6.9 K to 6 K (-13.44 %) |
| Aug 19 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 64.71 | 11,400 | 737,694 | 6,932 | 18.3 K to 6.9 K (-62.19 %) |
| Aug 19 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 64.70 | 3,700 | 239,390 | 18,332 | 22 K to 18.3 K (-16.79 %) |
| Aug 19 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Sell | S | 64.65 | 14,000 | 905,100 | 22,032 | 36 K to 22 K (-38.85 %) |
| Aug 19 2004 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Buy | M | 6.59 | 30,032 | 198,025 | 36,032 | 6 K to 36 K (+500.53 %) |
| Aug 13 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Option Exercise | M | 14.59 | 60,000 | 875,628 | 173,148 | |
| Aug 13 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Option Exercise | M | 6.53 | 5,000 | 32,657 | 13,316 | |
| Aug 13 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Sell | S | 65.77 | 7,500 | 493,275 | 207,058 | 214.6 K to 207.1 K (-3.50 %) |
| Aug 13 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Sell | S | 65.63 | 5,000 | 328,150 | 214,558 | 219.6 K to 214.6 K (-2.28 %) |
| Aug 13 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Sell | S | 65.52 | 5,000 | 327,600 | 219,558 | 224.6 K to 219.6 K (-2.23 %) |
| Aug 13 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Sell | S | 65.55 | 25,000 | 1,638,750 | 224,558 | 249.6 K to 224.6 K (-10.02 %) |
| Aug 13 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Sell | S | 65.60 | 7,500 | 492,000 | 249,558 | 257.1 K to 249.6 K (-2.92 %) |
| Aug 13 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Sell | S | 65.71 | 10,000 | 657,100 | 257,058 | 267.1 K to 257.1 K (-3.74 %) |
| Aug 13 2004 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | SVP, Research | Buy | M | 6.53 | 5,000 | 32,657 | 267,058 | 262.1 K to 267.1 K (+1.91 %) |